aTyr Pharma (NASDAQ:ATYR) just reported results for the second quarter of 2023.
- aTyr Pharma reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -28 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
aTyr Pharma (NASDAQ:ATYR) just reported results for the second quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/06/atyr-stock-earnings-atyr-pharma-for-q2-of-2023/.
©2025 InvestorPlace Media, LLC